Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.

Nabeel KhanNadim MahmudManthankumar PatelRamaswamy SundararajanWalter Reinisch

Published in: Alimentary pharmacology & therapeutics (2023)

In a nationwide cohort of IBD patients, we found that risk of serious infections could possibly be affected by behavioural modifications due to SARS-COV-2 pandemic.

Keyphrases

sars cov
patients with inflammatory bowel disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
chronic kidney disease
coronavirus disease
prognostic factors
cross sectional
peritoneal dialysis
early onset
patient reported outcomes